Cease
Cease, licence 80072446: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Genus Research and Consulting
- NPN or DIN-HM
- 80072446
- Status
- Inactive licence
- Licence date
- 8 September 2016
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido-[1,2-alpha][1,5]diazocin-8-one | 1.5 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Croscarmellose de sodium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Comprimé | minimum: 1.0 Tous les jours ; maximum: 6.0 Tous les jours |
Uses authorised in Canada
Stop smoking aid. Use as an aid for those who want to stop smoking cigarettes or break the cigarette habit, when used as part of a smoking cessation program. Intended to be used as part of a smoking cessation strategy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding, have a history of psychiatric disorders, an exacerbated peptic ulcer, ischemic heart disease, cardiac impairment, cerebrovascular disease, high blood pressure, hyperthyroidism, diabetes mellitus, renal or hepatic insufficiency or for use beyond 25 days. May cause sleep disorders. Do not exceed recommended dose. Symptoms of an overdose include nausea, abdominal pain, vomiting, diarrhea, cold sweats, dizziness, disturbed hearing and vision, mental confusion, rapid heartbeat, difficulty breathing and marked weakness. For adult use only, keep out of reach of children.
Source
Official Health Canada record, licence 80072446
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.